| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638541A2 Therapeutic agent for soft tissue sarcoma |
| 03/29/2006 | EP1638528A2 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 03/29/2006 | EP1638509A2 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1476190B1 Amino-substituted hypocrellins for use as sonosensitizers |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1409539B1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2006 | EP1346039B1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/29/2006 | EP1332137B1 Treatment of gastrointestinal stromal tumors |
| 03/29/2006 | EP1289552B1 Methods for treating hemostatic disorders by soluble p-selectin |
| 03/29/2006 | EP1227086B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 03/29/2006 | EP1226279B1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
| 03/29/2006 | EP1210113B1 Combined vaccine compositions |
| 03/29/2006 | EP1181376B1 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 03/29/2006 | EP1156789B1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP1012331B1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0973518B1 Semi-synthetic studies toward didemnin analogues |
| 03/29/2006 | EP0971585B1 Tetracycline compounds in the treatment of certain types of cancers |
| 03/29/2006 | EP0944722B1 Pituitary-tumor-transforming-genes, and related products |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1754002A Methods and compositions concerning poxviruses and cancer |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753991A Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 03/29/2006 | CN1753889A Quinazoline compounds |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753684A Improved antitumoral treatments |
| 03/29/2006 | CN1752104A Monoclonal antibody of synapse protein gamma and its application |
| 03/29/2006 | CN1752100A Marine organism anticancer protein and its extraction method |
| 03/29/2006 | CN1752097A C17-hydroxy-steroid lactone antitumour medicine |
| 03/29/2006 | CN1752095A C27-steroid antitumour medicine |
| 03/29/2006 | CN1752088A Medicinal composition containing timeazoamine ester |
| 03/29/2006 | CN1752078A Aibomycin analogue, its preparation method, medicinal composition and use |
| 03/29/2006 | CN1751743A Method for preparing 131I marker GM-CSF protein for treating leukemia |
| 03/29/2006 | CN1751741A Nano carbon tube infusion agent, its prepn. method and application in treating cancer, cardiovascular disease and infectious disease |
| 03/29/2006 | CN1751708A Method for extracting active component of radix scutellariae |
| 03/29/2006 | CN1751701A Medicine composition for inhibiting growth or transference of tumor cells |
| 03/29/2006 | CN1751694A Polyporus frondosus oral liquor and its prodn. method |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247767C Process for producing a culture of antrodia camphorata and product obtained thereby |
| 03/29/2006 | CN1247614C Preparation of antigen sensitized human dendron shaped cell and its use |
| 03/29/2006 | CN1247610C 23 position heteroatom substituted analogue of tiger's eye rohdea saponin OSW-1 kind saponin and its synthesis method and use |
| 03/29/2006 | CN1247608C Gene therapeutic drug hdm2-siRNA for breast cancer |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247569C Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247258C Combination therapy using anti-angiogenic agents and TNF alpha |
| 03/29/2006 | CN1247253C Oral adjuvant for treating cancer and its manufacturing method |
| 03/29/2006 | CN1247244C A series of Chinese traditional medicine for treating blood disease |
| 03/29/2006 | CN1247232C Radix zanthoxyli powder injection |
| 03/29/2006 | CN1247223C Method for preparing greater celandine extract with anticancer action |
| 03/29/2006 | CN1247209C Chinese traditional medicine for treating ovary cyst and preparing pocess |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/28/2006 | US7019156 Complex derivatives of bis(2-acetylpyridinethiosemicarbazonato-N1,N2,S)gallium(III) as anticarcinogenic agents |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019031 By deactivation of the prenylation enzyme through covalent modification; method for screening for cancer drugs by ability to inhibit prenylation |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019017 Small molecule inhibitors of HER2 expression |
| 03/28/2006 | US7019014 Process for producing anticancer agent LL-D45042 |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7019002 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018993 Androstane derivatives having various substituents at positions 7 and/or 11, a prophylactic or therapeutic agent for a disease selected from prostate cancer, benign prostatic hyperplasia, alopecia, acne, precocioous puberty |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018658 Pharmaceutical pellets comprising tamsulosin |
| 03/28/2006 | US7018632 Isolation of tumor cells; incubation |
| 03/28/2006 | US7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2291892C Angiostatin fragments and method of use |
| 03/28/2006 | CA2253912C Taxane derivatives, the preparation thereof and formulations containing them |
| 03/28/2006 | CA2244862C Substituted amide derivatives |
| 03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
| 03/28/2006 | CA2096723C Methods and compositions for the suppression of neu mediated transformation |